Amato Giaccia
Founder at Arresto BioSciences, Inc.
Net worth: 150 492 $ as of 2023-12-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Eric Zhang | M | 43 |
Aravive Biologics, Inc.
 Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX.
AKSO Biopharmaceutical, Inc.
| 8 years |
| Michael Snyder | M | - |
Stanford University School of Medicine
| 15 years |
| Thomas Neukranz | M | 66 |
Stanford Cancer Institute
| 8 years |
| Yu Miao | M | - |
AKSO Biopharmaceutical, Inc.
| - |
| Mike T. Longaker | M | - |
Arresto BioSciences, Inc.
 Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | 17 years |
| Simon Stertzer | M | 88 |
Stanford University School of Medicine
| 26 years |
| Joseph Wolk | M | 57 |
Stanford University School of Medicine
| - |
| Oliver Dorigo | M | - |
Stanford University School of Medicine
| - |
| Bruno C. Medeiros | M | - |
Stanford University School of Medicine
| - |
| Philip Hanno | M | - |
Stanford University School of Medicine
| 8 years |
| Calvin J. Kuo | M | - |
Stanford University School of Medicine
| - |
| John W. Day | M | - |
Stanford University School of Medicine
| 13 years |
| Walter Greenleaf | M | - |
Stanford University School of Medicine
| 7 years |
| Mark A. Kay | M | 66 |
Stanford University School of Medicine
| 26 years |
| George W. Sledge | M | 73 |
Stanford University School of Medicine
| - |
| Alejandro Dorenbaum | M | 64 |
Stanford University School of Medicine
| - |
| Sandra Horning | M | 75 |
Stanford University School of Medicine
| - |
| Glenn Matthew Chertow | M | - |
Stanford University School of Medicine
| - |
| Theodore Tussing | M | - |
Stanford University School of Medicine
| - |
| Vikram Bajaj | M | 46 |
Stanford University School of Medicine
| 10 years |
| Stefan Heller | M | 58 |
Stanford University School of Medicine
| - |
| Alyce S. Adams | M | - |
Stanford Cancer Institute
| - |
| Phil Yang | M | - |
Stanford University School of Medicine
| - |
| Maria Petrini | F | - | 1 years | |
| Mintu Turakhia | M | 50 |
Stanford University School of Medicine
| 16 years |
| Jennifer Rosingana | F | - |
Stanford University School of Medicine
| - |
| Chris Zeise | M | - |
Stanford University School of Medicine
| - |
| Christi Opitz | F | - |
Stanford University School of Medicine
| - |
| Judith Ned | F | - |
Stanford University School of Medicine
| - |
| Susan Hoerger | F | - |
Stanford University School of Medicine
| - |
| Stephen Galli | M | 77 |
Stanford University School of Medicine
| 25 years |
| Gary Berke | M | - |
Stanford University School of Medicine
| - |
| Henry Greely | M | - |
Stanford University School of Medicine
| - |
| Kiki Chang | M | - |
Stanford University School of Medicine
| - |
| Hannah Valantine | M | 72 |
Stanford University School of Medicine
| 37 years |
| Ryan Spitler | M | - |
Stanford University School of Medicine
| 8 years |
| Jody Gould | M | - | 3 years | |
| Sachie Oshima | M | 52 |
Stanford University School of Medicine
| 17 years |
| Thomas C. Südhof | M | 68 |
Stanford University School of Medicine
| - |
| Francis McCormick | M | 73 |
Arresto BioSciences, Inc.
Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | - |
| Ramon Chavez Márquez | M | 60 |
Stanford University School of Medicine
| 9 years |
| Christopher Viehbacher | M | 64 |
Stanford University School of Medicine
| - |
| Emmett Cunningham | M | 63 |
Stanford University School of Medicine
| 16 years |
| David Karpf | M | 69 |
Stanford University School of Medicine
| - |
| Joseph Wu | M | - |
Stanford University School of Medicine
| 11 years |
| George Tidmarsh | M | 64 |
Stanford University School of Medicine
| 14 years |
| Eugene Bauer | M | 81 |
Stanford University School of Medicine
| 36 years |
| Lucy Shapiro | M | 83 |
Stanford University School of Medicine
| 35 years |
| Daria Mochly-Rosen | M | - |
Stanford University School of Medicine
| - |
| Peter Fitzgerald | M | 66 |
Stanford University School of Medicine
| 27 years |
| Lawrence Steinman | M | 76 |
Stanford University School of Medicine
| - |
| Edgar Engleman | M | 78 |
Stanford University School of Medicine
| 34 years |
| Paul A. Berg | M | 97 |
Stanford University School of Medicine
| - |
| Steven J. Chu | M | 76 |
Stanford University School of Medicine
| 11 years |
| Peter Kim | M | 65 |
Stanford University School of Medicine
| 10 years |
| William J. Maloney | M | - |
Stanford University School of Medicine
| 20 years |
| Michelle Brandt | F | - |
Stanford University School of Medicine
| - |
| James Newman | M | - |
Stanford University School of Medicine
| - |
| Eddie C. Cheung | M | - |
Stanford University School of Medicine
| - |
| Victoria Smith | M | - |
Arresto BioSciences, Inc.
Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | 17 years |
| Leonard Dove | M | 51 | 2 years | |
| Dung Thai | M | - |
Arresto BioSciences, Inc.
Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | 15 years |
| Jeffrey Glenn | M | 61 |
Stanford University School of Medicine
| 24 years |
| K. Christopher Garcia | M | - |
Stanford University School of Medicine
| 25 years |
| Jillian Manus | F | - |
Stanford University School of Medicine
| 6 years |
| Paul Blumenthal | M | - |
Stanford University School of Medicine
| - |
| Emmet B. Keeffe | M | - |
Stanford University School of Medicine
| - |
| Garry Nolan | M | 63 |
Stanford University School of Medicine
| - |
| Thomas Krummel | M | 72 |
Stanford University School of Medicine
| - |
| Geoff C. Gurtner | M | - |
Arresto BioSciences, Inc.
Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | 17 years |
| Roger Kornberg | M | 76 |
Stanford University School of Medicine
| 46 years |
| Thomas Vardell | M | 55 |
Arresto BioSciences, Inc.
Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | - |
| Thomas Raffin | M | 77 |
Stanford University School of Medicine
| - |
| Lawrence M. Shuer | M | - |
Stanford University School of Medicine
| - |
| Terrence Blaschke | M | 81 |
Stanford University School of Medicine
| 50 years |
| James Gillespie | M | - |
Stanford University School of Medicine
| 7 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Raymond Tabibiazar | M | 53 |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | 11 years |
| Jay Shepard | M | 66 | 7 years | |
| Rekha Hemrajani | F | 54 | - | |
| Srini Akkaraju Akkaraju | M | 56 | - | |
| Peter van Vlasselaer | M | 64 |
Arresto BioSciences, Inc.
Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | 4 years |
| Mohammed Malik | M | 56 | - | |
| John Hohneker | M | 64 | 3 years | |
| Sigurd Kirk | M | 57 | 3 years | |
| Rudy Howard | M | 67 | 2 years | |
| Kevin Haas | M | 59 | - | |
| Michael Rogers | M | 64 | 4 years | |
| Stephen Eck | M | 69 |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | 1 years |
| Fred Eshelman | M | 76 | 4 years | |
| Tai Ching Ho | M | 62 | 3 years | |
| Robert Hoffman | M | 58 | 2 years | |
| Jean-Michel Vernier | M | 63 |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | 1 years |
| Amy Franke | F | - | - | |
| Tracy Woody | F | 54 | 1 years | |
| Vinay Shah | M | 62 | 4 years | |
| Elisabeth M. M. Gardiner | M | - | 2 years | |
| Scott Ogg | M | 57 |
Arresto BioSciences, Inc.
Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | 4 years |
| Howard H. Pien | M | 66 |
Arresto BioSciences, Inc.
Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | 1 years |
| James L. Freddo | M | 69 |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | - |
| Reshma Rangwala | M | 46 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Amato Giaccia
- Personal Network
